Flibanserin Fails To Improve Sexual Desire, FDA Advisory Committee Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Boehringer Ingelheim unable to show sufficient efficacy for Girosa in hypoactive sexual desire disorder in women.